Popular Articles

Bill Would Allow Federal Funding For Needle Exchange Programs
House Democrats on Friday as part of a spending measure to fund the Departments of Labor and HHS for fiscal year 2010, "unveiled legislation to lift a ban on federal funding for needle-exchange programs, a shift to try to reduce [HIV infections] but one that will probably spark a fight," Reuters/Boston Globe reports (7/11). The ban has been included in the annual spending bill in previous years. House Appropriations Committee Chair David Obey (D-Wis.) said, "Scientific studies have documented that needle exchange programs, when implemented as part of a comprehensive prevention strategy, are an effective public health intervention for reducing [HIV] infections and do not promote drug use" (Reuters, Pelofsky, 7/10). "The move is in keeping with a pledge [President] Obama made during the primaries to remove the prohibition on such funding, although the ban was carried in his budget request this year," CQ Today reports (Wolfe, 7/10). However, "Republicans are girding for a fight over the ban and lawmakers could try to restore it as the legislation moves through the House during the next two weeks," according to Reuters (7/10). The bill also addresses sex education and "appears to continue Democrats" slow march away from funding abstinence-only sex education," CQ reports (7/10).
pharmacy online
Evaluating The ADHD Medication VYVANSE CII Demonstrated No Change In Pharmacokinetic Profile Of VYVANSE When Coadministered With Prilosec OTC 40 Mg
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication VYVANSE® (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PPI) Prilosec OTC® 40 mg (20 mg X 2), did not alter the median time it took for maximum plasma concentration of d-amphetamine to be reached in the subjects evaluated. In the same study, coadministration of Prilosec OTC with ADDERALL XR resulted in a nearly 45 percent reduction in the median time to reach maximum plasma concentrations of amphetamine, the active medication. Other pharmacokinetic parameters (maximum plasma concentration and area under curve) of active medication were not altered for either VYVANSE or ADDERALL XR when coadministered with Prilosec OTC. This study, which is the first to evaluate the pharmacokinetics of VYVANSE and ADDERALL XR taken alone and with Prilosec OTC 40 mg, was recently presented at the International Congress on Clinical Pharmacy, co-sponsored by the American College of Clinical Pharmacy (ACCP), in Orlando, FL.
News of the day
Novartis To Partner With OneWorld Health To Develop Diarrhea Drug
"Swiss drug company Novartis AG and the Institute for OneWorld Health, a nonprofit group, will announce this week a partnership to discover drugs for a type of diarrhea that kills about 1.6 million children each year in the developing world," the Wall Street Journal reports.
Oncology

Seniors Seek Help With Medicare's 'Doughnut Hole'

Senior and elderly advocate groups are calling on Congress to get rid of the "doughnut hole" in Medicare"s drug benefit as part of the larger efforts to reform health care, according to The Dallas Morning News. The "doughnut hole" forces millions of Medicare beneficiaries to bear the full cost of their drugs for a period of time once they exceed $2,700. "Unless they qualify for a government subsidy or have bought extra insurance, they"re on their own for the next $3,454 in prescriptions. At that point, after paying a total of $4,350 out of pocket, beneficiaries become eligible for Medicare"s catastrophic coverage and are responsible for 5 percent of their bills for the rest of the year," The Dallas Morning News reports. The gap exists because Congress had only so much to spend when it created the Medicare drug program and the main challenge in correcting it is money: "Closing the gap and providing continuous coverage for all beneficiaries would cost $134 billion over 10 years, according to the Congressional Budget Office." Still, "experts say that as much as $110 billion could be raised by requiring drug manufacturers to give Medicare the same 15 percent discount they now give Medicaid, the health insurance program for low-income Americans." "More than 3 million of the nearly 27 million older or disabled Americans who receive the Medicare drug benefit are expected to reach the coverage gap this year and pay the full cost of their prescriptions, says the AARP Public Policy Institute." AARP also "projects that the size of the gap will almost double, from $3,454 to more than $6,000, by 2016." Beneficiaries with chronic or serious illnesses often experience severe hardship and "sixteen percent of beneficiaries who hit the gap reduce their medication or stop taking their drugs altogether, says the Kaiser Family Foundation (KHN is a program of the Kaiser Family Foundation). Advocates say that "eliminating the doughnut hole would probably reap savings for Medicare over the long run, since it would keep seniors on their prescriptions and out of the hospital." If completely closing the hole isn"t possible, advocates recommend at least narrowing it. That could be done by allowing more Medicare drug beneficiaries to qualify for the government"s low-income subsidy or "mandating the coverage of generic drugs through the gap and offsetting the added expense to the government by charging larger co-payments before consumers reach the doughnut hole" (6/8, Moos). Meanwhile, WSPA Channel 7, a Media General station, reports that South Carolina lawmakers increased the amount the state will pay for its seniors who fall in the Medicare Part D doughnut hole from 10 percent up to 30 percent starting July 1. Jeff Stensland, spokesman for the South Carolina Department of Health and Human Services, says "about 25,000 South Carolinians qualify for the program but he doesn"t know how many actually reach the "donut hole" and receive assistance" (Kittle, 6/8). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):